WebDiogo A Bastos, 1 Emmanuel S Antonarakis 2 1 Department of Oncology, Hospital Sirio-Libanes, Sao Paulo, SP, Brazil; 2 Departments of Oncology and Urology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA Correspondence: Emmanuel S Antonarakis Department of Oncology and Urology, … WebCastration-resistant prostate cancer (CRPC) is cancer that continues to grow even when the testosterone levels are at or below the castrate level. It can also be called hormone-refractory or hormone-resistant prostate cancer. Non-metastatic castration-resistant …
Androgen Receptor Targeted Agents for Castration Resistant ... - P…
WebJan 20, 2024 · Castration-resistant prostate cancer: Treatments targeting the androgen pathway; Chemotherapy in advanced castration-resistant prostate cancer; Genetic risk factors for prostate cancer; Immunotherapy for castration-resistant prostate cancer; … WebJun 25, 2014 · Our results suggest that ODM-201 monotherapy in men with progressive metastatic castration-resistant prostate cancer provides disease suppression and that ODM-201 has a favourable safety profile. These findings support further investigation of clinical responses with ODM-201 in men with castration-resistant prostate cancer. forden\\u0027s fireplace shop
Overview of the treatment of castration-resistant prostate …
WebJun 8, 2024 · Rucaparib is a PARP inhibitor approved in the United States for the treatment of patients with deleterious BRCA1 or BRCA2 (BRCA) mutation-associated metastatic castration-resistant prostate cancer (mCRPC) who have been treated with androgen receptor-directed therapy and a taxane-based chemotherapy [].The accelerated approval … WebThere is evidence to suggest that although castration removes the gonadal testosterone in prostate cancer, androgens originating from other sources, including the adrenal gland and, intriguingly, the prostate cancer itself, may continue to act as a ligand and result in … WebFeb 2, 2024 · Castration-Naive Source National Cancer Institute. Castration-Naive. NCI Thesaurus. Code C148540. A finding indicating that an advanced prostate carcinoma was not previously treated with androgen-deprivation therapy. Open Peer Review No peer reviews yet for this version. Sign Up as Researcher to review it or Suggest for a Review ford enhanced diagnostics add-on